Refine
Year of publication
Document Type
- Preprint (478)
- Article (347)
- Doctoral Thesis (1)
- Working Paper (1)
Has Fulltext
- yes (827)
Is part of the Bibliography
- no (827)
Keywords
- Hadron-Hadron scattering (experiments) (11)
- Heavy Ion Experiments (10)
- Heavy-ion collision (4)
- Heavy-ion collisions (4)
- Diffraction (3)
- Elastic scattering (3)
- Hadron-Hadron Scattering (3)
- stroke (3)
- Beam Energy Scan (2)
- CRM (2)
- Charm physics (2)
- Chiral Magnetic Effect (2)
- Collectivity (2)
- Correlation (2)
- Depression (2)
- Elliptic flow (2)
- Energiebereitstellung (2)
- Entzündung (2)
- Genome-wide association studies (2)
- Gewebedurchblutung (2)
- Gewebetemperatur (2)
- Heavy Ions (2)
- Infektionsabwehr (2)
- LHC (2)
- Lebensqualität (2)
- Parkinson’s disease (2)
- Pb–Pb collisions (2)
- Polarization (2)
- Predictive markers (2)
- Problemwunden (2)
- RHIC (2)
- STAR (2)
- Sauerstoffpartialdruck im Gewebe (2)
- Sauerstoffversorgung (2)
- Schmerzminderung (2)
- Shear viscosity (2)
- Wundheilung (2)
- Wundinfektionen (2)
- Wundsekretion (2)
- acute wounds (2)
- akute Wunden (2)
- biodiversity protection (2)
- conservation funding (2)
- conservation planning (2)
- decision making (2)
- energy supply (2)
- global change (2)
- infection defense (2)
- inflammation (2)
- oxygen supply (2)
- post-2020 biodiversity targets (2)
- problem wounds (2)
- prospective, randomized, controlled, double-blind studies (2)
- reduction of pain (2)
- strategic site selection (2)
- temperaturabhängige und temperaturunabhängige Effekte (2)
- thermal and non-thermal effects (2)
- thermic and non-thermic effects (2)
- thermische und nicht-thermische Effekte (2)
- tissue blood flow (2)
- tissue oxygen partial pressure (2)
- tissue temperature (2)
- visual analog scales (VAS) (2)
- visuelle Analogskalen (VAS) (2)
- wassergefiltertes Infrarot A (wIRA) (2)
- water-filtered infrared-A (wIRA) (2)
- wound exudation (2)
- wound healing (2)
- wound infections (2)
- ACLF (1)
- ADHD (1)
- ALICE detector (1)
- ALICE experiment (1)
- Active middle ear implants (1)
- Alleles (1)
- Anti-nuclei (1)
- Antirheumatic agents (1)
- Artificial Intelligence (1)
- Asset Purchase Programme (1)
- Auditory system (1)
- B-slope (1)
- BK channel (1)
- Beam energy scan (1)
- Big Five (1)
- Biodiversity Data (1)
- Biomarkers (1)
- Biomonitoring (1)
- Bipolar disorder (1)
- Bone conduction devices (1)
- Botanical Collections (1)
- CDH13 (1)
- CLIF-C ACLF score (1)
- CLIF-C ACLF-R score (1)
- Caenorhabditis elegans (1)
- Canonical suppression (1)
- Central Bank Communication (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charged-particle multiplicity (1)
- Charm quark spatial diffusion coefficient (1)
- Charmonia (1)
- Child (1)
- Chiral magnetic effect (1)
- Cleanliness level (1)
- Clinical Trials and Observations (1)
- Clinical presentation (1)
- ClpB (1)
- Coalescence (1)
- Cold nuclear matter effects (1)
- Colon capsule endoscopy (1)
- Comparative effectiveness research (1)
- Complementation rate (1)
- Complexin 1 (1)
- Consensus (1)
- Consensus statement (1)
- Conservation (1)
- Consortia (1)
- Critical point (1)
- DNA methylation (1)
- Dermatomyositis (1)
- Deuteron production (1)
- Di-hadron correlations (1)
- Diagnosis (1)
- Digitization (1)
- ERAL1 (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Emotions (1)
- Energieumsatz <Medizin> (1)
- Etiology (1)
- Fibre/foam sandwich radiator (1)
- Flow (1)
- Forward Guidance (1)
- Forward physics (1)
- Genetics (1)
- Genetics research (1)
- Goodman (1)
- Groomed jet radius (1)
- HARS2 (1)
- HIV (1)
- Hadronization (1)
- Health policy (1)
- Heavy Quark Production (1)
- Heavy ion collisions (1)
- Heavy ions (1)
- Heavy-Ion Collision (1)
- Heavy-flavor decay electron (1)
- Heavy-flavour decay muons (1)
- Heavy-ion (1)
- Herbaria (1)
- Higher moments (1)
- Human behaviour (1)
- Hyperammonemic encephalopathy (1)
- Hypertension (1)
- Incomplete colonoscopy (1)
- Infrarot (1)
- Interference fragmentation function (1)
- Invariant Mass Distribution (1)
- Ionisation energy loss (1)
- J/ψ suppression (1)
- Jet substructure (1)
- LARS2 (1)
- Lepton-Nucleon Scattering (experiments) (1)
- Low volume prep (1)
- Lymphoid Neoplasia (1)
- Mental health and psychiatry (1)
- Minimum Bias (1)
- Mixed hearing loss (1)
- Molecular genetics (1)
- Molecular neuroscience (1)
- Monte Carlo (1)
- Moviprep (1)
- Multi-stakeholder approach (1)
- Multi-wire proportional drift chamber (1)
- Multiple parton interactions (1)
- NS1608 (1)
- NSAIDs (1)
- Nelson (1)
- Neolithic (1)
- Neonatal urea cycle disorders (1)
- Net-charge correlations (1)
- Net-charge fluctuations (1)
- Neumann (1)
- Neural network (1)
- Nonflow (1)
- OPRM1 methylation (1)
- PARK4 (1)
- PRG-1 (1)
- Parodie (1)
- Particle and resonance production (1)
- Particle correlations and fluctuations (1)
- Particle production (1)
- Personalized medicine (1)
- Phospho-soda (1)
- PillCamColon2 (1)
- Polyps (1)
- Production Cross Section (1)
- Proton-proton collisions (1)
- Proton–proton collisions (1)
- Psychiatric disorders (1)
- Psychometrics (1)
- QCD (1)
- Quark gluon plasma (1)
- Quarkonium (1)
- Quark–gluon plasma (1)
- Questionnaires (1)
- Radiotherapy (1)
- Rapid eye movement sleep behavior disorder (1)
- Rapidity Range (1)
- Rehabilitation (1)
- Relativistic heavy ion physics (1)
- Research Infrastructure (1)
- Resolution Parameter (1)
- Resonances (1)
- Rheumatoid arthritis (1)
- Rheumatology (1)
- Robert (1)
- SARS-CoV-2 (1)
- SNP (1)
- Schizophrenia (1)
- Schmerz (1)
- Sekretion (1)
- Semantics (1)
- Semiotik (1)
- SoftDrop (1)
- Spin alignment (1)
- Splitting function (1)
- Strangeness enhancement (1)
- Surgery (1)
- Surgical oncology (1)
- Systematic Uncertainty (1)
- TR (1)
- TWNK (1)
- Taxonomy (1)
- Technical data (1)
- Thermal model (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transition radiation detector (1)
- Transversity (1)
- Trigger (1)
- Unconventional Monetary Policy (1)
- Viral infection (1)
- Wunde (1)
- Wundinfektion (1)
- Xenon-based gas mixture (1)
- acute-on-chronic liver failure (1)
- adenylyl cyclases (1)
- agreeableness (1)
- angiopoietin-like 3 (ANGPTL3) (1)
- antibodies (1)
- ataxia (1)
- axions (1)
- b-cell lymphomas (1)
- bendamustine (1)
- bioactive phospholipids (1)
- biodiversity change (1)
- biomarker (1)
- bortezomib (1)
- chemotherapy (1)
- chemotherapy regimen (1)
- chimeric antigen receptor t-cell therapy (1)
- chimeric antigen receptors (1)
- cortical network (1)
- cyclic nucleotide-gated channels (1)
- dE/dx (1)
- dark matter experiments (1)
- domestication (1)
- doppeltblinde Studien (1)
- emergency care (1)
- evolution (1)
- executive functions (1)
- gene flow (1)
- global biodiversity framework (1)
- guanylyl cyclases (1)
- heavy ion experiments (1)
- heavy-ion collisions (1)
- hematopoietic stem cell transplantation (1)
- hepatitis C (1)
- human brain (1)
- implementation (1)
- induction regimen (1)
- kidney (1)
- kidney function (1)
- kontrollierte Studien (1)
- lenalidomide (1)
- leukapheresis (1)
- leukodystrophy (1)
- leukopenia (1)
- long-term protection (1)
- long36 term protection (1)
- lymphoma (1)
- mainstreaming (1)
- mechanical ventilation (1)
- monitoring (1)
- multiple myeloma (1)
- muscle disease (1)
- myotonia congenita (1)
- neurodevelopment (1)
- neuromuscular system (1)
- neutropenia (1)
- optogenetics (1)
- p+p collisions (1)
- paxilline (1)
- polymorphism (1)
- prognosis (1)
- prospektive Studien (1)
- prospektive, randomisierte, kontrollierte, doppeltblinde Studien (1)
- psychiatric disorders (1)
- pulmonary failure (1)
- quality of lif (1)
- quality of life (1)
- quark gluon plasma (1)
- randomisierte Studien (1)
- remote responsibility (1)
- renal failure (1)
- repetitive firing (1)
- respiratory failure (1)
- restoration (1)
- rhodopsin (1)
- rituximab (1)
- scenario (1)
- simulation (1)
- simulation training (1)
- solar physics (1)
- sphingolipid (1)
- synapse (1)
- thrombolysis (1)
- thrombolysis (tPA) (1)
- training (1)
- values (1)
- white and brown dwarfs (1)
- working memory (1)
- Υ suppression (1)
- α-synuclein (1)
- μ-opioid receptor regulation (1)
Institute
The antibody-drug conjugate polatuzumab vedotin (pola) has recently been approved in combination with bendamustine and rituximab (pola-BR) for patients with refractory or relapsed (r/r) large B-cell lymphoma (LBCL). To investigate the efficacy of pola-BR in a real-world setting, we retrospectively analyzed 105 patients with LBCL who were treated in 26 German centers under the national compassionate use program. Fifty-four patients received pola as a salvage treatment and 51 patients were treated with pola with the intention to bridge to chimeric antigen receptor (CAR) T-cell therapy (n = 41) or allogeneic hematopoietic cell transplantation (n = 10). Notably, patients in the salvage and bridging cohort had received a median of 3 prior treatment lines. In the salvage cohort, the best overall response rate was 48.1%. The 6-month progression-free survival and overall survival (OS) was 27.7% and 49.6%, respectively. In the bridging cohort, 51.2% of patients could be successfully bridged with pola to the intended CAR T-cell therapy. The combination of pola bridging and successful CAR T-cell therapy resulted in a 6-month OS of 77.9% calculated from pola initiation. Pola vedotin-rituximab without a chemotherapy backbone demonstrated encouraging overall response rates up to 40%, highlighting both an appropriate alternative for patients unsuitable for chemotherapy and a new treatment option for bridging before leukapheresis in patients intended for CAR T-cell therapy. Furthermore, 7 of 12 patients with previous failure of CAR T-cell therapy responded to a pola-containing regimen. These findings suggest that pola may serve as effective salvage and bridging treatment of r/r LBCL patients.
Mapping cortical brain asymmetry in 17,141 healthy individuals worldwide via the ENIGMA Consortium
(2017)
Background: The human chromosomal region 9p21.3 has been shown to be strongly associated with Coronary Heart Disease (CHD) in several Genome-wide Association Studies (GWAS). Recently, this region has also been shown to be associated with Aggressive Periodontitis (AgP), strengthening the hypothesis that the established epidemiological association between periodontitis and CHD is caused by a shared genetic background, in addition to common environmental and behavioural risk factors. However, the size of the analyzed cohorts in this primary analysis was small compared to other association studies on complex diseases. Using our own AgP cohort, we attempted to confirm the described associations for the chromosomal region 9p21.3. Methods: We analyzed our cohort consisting of patients suffering from the most severe form of AgP, generalized AgP (gAgP) (n = 130) and appropriate periodontally healthy control individuals (n = 339) by genotyping four tagging SNPs (rs2891168, rs1333042, rs1333048 and rs496892), located in the chromosomal region 9p21.3, that have been associated with AgP. Results: The results confirmed significant associations between three of the four SNPs and gAgP. The combination of our results with those from the study which described this association for the first time in a meta-analysis of the four tagging SNPs produced clearly lower p-values compared with the results of each individual study. According to these results, the most plausible genetic model for the association of all four tested SNPs with gAgP seems to be the multiplicative one. Conclusion: We positively replicated the finding of an association between the chromosomal region 9p21.3 and gAgP. This result strengthens support for the hypothesis that shared susceptibility genes within this chromosomal locus might be involved in the pathogenesis of both CHD and gAgP.
Introduction: Acute stroke care delivered by interdisciplinary teams is time-sensitive. Simulation-based team training is a promising tool to improve team performance in medical operations. It has the potential to improve process times, team communication, patient safety, and staff satisfaction. We aim to assess whether a multi-level approach consisting of a stringent workflow revision based on peer-to-peer review and 2–3 one-day in situ simulation trainings can improve acute stroke care processing times in high volume neurocenters within a 6 months period.
Methods and Analysis: The trial is being carried out in a pre-test-post-test design at 7 tertiary care university hospital neurocenters in Germany. The intervention is directed at the interdisciplinary multiprofessional stroke teams. Before and after the intervention, process times of all direct-to-center stroke patients receiving IV thrombolysis (IVT) and/or endovascular therapy (EVT) will be recorded. The primary outcome measure will be the “door-to-needle” time of all consecutive stroke patients directly admitted to the neurocenters who receive IVT. Secondary outcome measures will be intervention-related process times of the fraction of patients undergoing EVT and effects on team communication, perceived patient safety, and staff satisfaction via a staff questionnaire.
Interventions: We are applying a multi-level intervention in cooperation with three “STREAM multipliers” from each center. First step is a central meeting of the multipliers at the sponsor's institution with the purposes of algorithm review in a peer-to-peer process that is recorded in a protocol and an introduction to the principles of simulation training and debriefing as well as crew resource management and team communication. Thereafter, the multipliers cooperate with the stroke team trainers from the sponsor's institution to plan and execute 2–3 one-day simulation courses in situ in the emergency department and CT room of the trial centers whereupon they receive teaching materials to perpetuate the trainings.
Clinical Trial Registration: STREAM is a registered trial at https://clinicaltrials.gov/ct2/show/NCT03228251.
Objectives: To investigate the prevalence of depressive symptoms in rheumatoid arthritis (RA) patients using two previously validated questionnaires in a large patient sample, and to evaluate depressive symptoms in the context of clinical characteristics (e.g. remission of disease) and patient-reported impact of disease.
Methods: In this cross-sectional study, the previously validated Patient Health Questionnaire (PHQ-9) and Beck-Depression Inventory II (BDI-II) were used to assess the extent of depressive symptoms in RA patients. Demographic background, RA disease activity score (DAS28), RA impact of disease (RAID) score, comorbidities, anti-rheumatic therapy and antidepressive treatment, were recorded. Cut-off values for depressive symptomatology were PHQ-9 ≥5 or BDI-II ≥14 for mild depressive symptoms or worse and PHQ-9 ≥ 10 or BDI-II ≥ 20 for moderate depressive symptoms or worse. Prevalence of depressive symptomatology was derived by frequency analysis while factors independently associated with depressive symptomatology were investigated by using multiple logistic regression analyses. Ethics committee approval was obtained, and all patients provided written informed consent before participation.
Results: In 1004 RA-patients (75.1% female, mean±SD age: 61.0±12.9 years, mean disease duration: 12.2±9.9 years, DAS28 (ESR): 2.5±1.2), the prevalence of depressive symptoms was 55.4% (mild or worse) and 22.8% (moderate or worse). Characteristics independently associated with depressive symptomatology were: age <60 years (OR = 1.78), RAID score >2 (OR = 10.54) and presence of chronic pain (OR = 3.25). Of patients classified as having depressive symptoms, only 11.7% were receiving anti-depressive therapy.
Conclusions: Mild and moderate depressive symptoms were common in RA patients according to validated tools. In routine clinical practice, screening for depression with corresponding follow-up procedures is as relevant as incorporating these results with patient-reported outcomes (e.g. symptom state), because the mere assessment of clinical disease activity does not sufficiently reflect the prevalence of depressive symptoms.
Clinical trial registration number: This study is registered in the Deutsches Register Klinischer Studien (DRKS00003231) and ClinicalTrials.gov (NCT02485483).
The cell—cell signaling gene CDH13 is associated with a wide spectrum of neuropsychiatric disorders, including attention-deficit/hyperactivity disorder (ADHD), autism, and major depression. CDH13 regulates axonal outgrowth and synapse formation, substantiating its relevance for neurodevelopmental processes. Several studies support the influence of CDH13 on personality traits, behavior, and executive functions. However, evidence for functional effects of common gene variation in the CDH13 gene in humans is sparse. Therefore, we tested for association of a functional intronic CDH13 SNP rs2199430 with ADHD in a sample of 998 adult patients and 884 healthy controls. The Big Five personality traits were assessed by the NEO-PI-R questionnaire. Assuming that altered neural correlates of working memory and cognitive response inhibition show genotype-dependent alterations, task performance and electroencephalographic event-related potentials were measured by n-back and continuous performance (Go/NoGo) tasks. The rs2199430 genotype was not associated with adult ADHD on the categorical diagnosis level. However, rs2199430 was significantly associated with agreeableness, with minor G allele homozygotes scoring lower than A allele carriers. Whereas task performance was not affected by genotype, a significant heterosis effect limited to the ADHD group was identified for the n-back task. Heterozygotes (AG) exhibited significantly higher N200 amplitudes during both the 1-back and 2-back condition in the central electrode position Cz. Consequently, the common genetic variation of CDH13 is associated with personality traits and impacts neural processing during working memory tasks. Thus, CDH13 might contribute to symptomatic core dysfunctions of social and cognitive impairment in ADHD.
Plants, fungi and algae are important components of global biodiversity and are fundamental to all ecosystems. They are the basis for human well-being, providing food, materials and medicines. Specimens of all three groups of organisms are accommodated in herbaria, where they are commonly referred to as botanical specimens.The large number of specimens in herbaria provides an ample, permanent and continuously improving knowledge base on these organisms and an indispensable source for the analysis of the distribution of species in space and time critical for current and future research relating to global biodiversity. In order to make full use of this resource, a research infrastructure has to be built that grants comprehensive and free access to the information in herbaria and botanical collections in general. This can be achieved through digitization of the botanical objects and associated data.The botanical research community can count on a long-standing tradition of collaboration among institutions and individuals. It agreed on data standards and standard services even before the advent of computerization and information networking, an example being the Index Herbariorum as a global registry of herbaria helping towards the unique identification of specimens cited in the literature.In the spirit of this collaborative history, 51 representatives from 30 institutions advocate to start the digitization of botanical collections with the overall wall-to-wall digitization of the flat objects stored in German herbaria. Germany has 70 herbaria holding almost 23 million specimens according to a national survey carried out in 2019. 87% of these specimens are not yet digitized. Experiences from other countries like France, the Netherlands, Finland, the US and Australia show that herbaria can be comprehensively and cost-efficiently digitized in a relatively short time due to established workflows and protocols for the high-throughput digitization of flat objects.Most of the herbaria are part of a university (34), fewer belong to municipal museums (10) or state museums (8), six herbaria belong to institutions also supported by federal funds such as Leibniz institutes, and four belong to non-governmental organizations. A common data infrastructure must therefore integrate different kinds of institutions.Making full use of the data gained by digitization requires the set-up of a digital infrastructure for storage, archiving, content indexing and networking as well as standardized access for the scientific use of digital objects. A standards-based portfolio of technical components has already been developed and successfully tested by the Biodiversity Informatics Community over the last two decades, comprising among others access protocols, collection databases, portals, tools for semantic enrichment and annotation, international networking, storage and archiving in accordance with international standards. This was achieved through the funding by national and international programs and initiatives, which also paved the road for the German contribution to the Global Biodiversity Information Facility (GBIF).Herbaria constitute a large part of the German botanical collections that also comprise living collections in botanical gardens and seed banks, DNA- and tissue samples, specimens preserved in fluids or on microscope slides and more. Once the herbaria are digitized, these resources can be integrated, adding to the value of the overall research infrastructure. The community has agreed on tasks that are shared between the herbaria, as the German GBIF model already successfully demonstrates.We have compiled nine scientific use cases of immediate societal relevance for an integrated infrastructure of botanical collections. They address accelerated biodiversity discovery and research, biomonitoring and conservation planning, biodiversity modelling, the generation of trait information, automated image recognition by artificial intelligence, automated pathogen detection, contextualization by interlinking objects, enabling provenance research, as well as education, outreach and citizen science.We propose to start this initiative now in order to valorize German botanical collections as a vital part of a worldwide biodiversity data pool.
In high-energy heavy-ion collisions, partonic collectivity is evidenced by the constituent quark number scaling of elliptic flow anisotropy for identified hadrons. A breaking of this scaling and dominance of baryonic interactions is found for identified hadron collective flow measurements in √sNN = 3 GeV Au+Au collisions. In this paper, we report measurements of the first- and second-order azimuthal anisotropic parameters, v1 and v2, of light nuclei (d, t, 3He, 4He) produced in √sNN = 3 GeV Au+Au collisions at the STAR experiment. An atomic mass number scaling is found in the measured v1 slopes of light nuclei at mid-rapidity. For the measured v2 magnitude, a strong rapidity dependence is observed. Unlike v2 at higher collision energies, the v2 values at mid-rapidity for all light nuclei are negative and no scaling is observed with the atomic mass number. Calculations by the Jet AA Microscopic Transport Model (JAM), with baryonic mean-field plus nucleon coalescence, are in good agreement with our observations, implying baryonic interactions dominate the collective dynamics in 3 GeV Au+Au collisions at RHIC.
Background: Neonatal manifestation of life-threatening hyperammonemic encephalopathy in urea cycle disorders (UCD) is often misdiagnosed as neonatal sepsis, resulting in significantly delayed start of specific treatment and poor outcome. The major aim of this study was to identify specific initial symptoms or signs to clinically distinguish hyperammonemic encephalopathy in neonates from neonatal sepsis in order to identify affected individuals with UCD and to start metabolic therapy without delay. Furthermore, we evaluated the impact of diagnostic delay, peak plasma ammonium (NH4+) concentration, mode of emergency treatment and transfer to a tertiary referral center on the outcome.
Methods: Detailed information of 17 patients (born between 1994 and 2012) with confirmed diagnosis of UCD and neonatal hyperammonemic encephalopathy were collected from the original medical records.
Results: The initially suspected diagnosis was neonatal sepsis in all patients, but was not confirmed in any of them. Unlike neonatal sepsis and not previously reported blood pressure increased above the 95th percentile in 13 (81%) of UCD patients before emergency treatment was started. Respiratory alkalosis was found in 11 (65%) of UCD patients, and in 14 (81%) plasma NH4+concentrations further increased despite initiation of metabolic therapy.
Conclusion: Detection of high blood pressure could be a valuable parameter for distinguishing neonatal sepsis from neonatal manifestation of UCD. Since high blood pressure is not typical for neonatal sepsis, other reasons such as encephalopathy and especially hyperammonemic encephalopathy (caused by e.g. UCD) should be searched for immediately. However, our result that the majority of newborns with UCD initially present with high blood pressure has to be evaluated in larger patient cohorts.
Aim: To evaluate the ability of PillCamColon2 to visualize colonic segments missed by incomplete optical colonoscopy (OC) and to assess the diagnostic yield.
Methods: This prospective multicentre study included 81 patients from nine centres who underwent second-generation colon capsule endoscopy (CCE) following incomplete OC performed by an experienced gastroenterologist (> 1000 colonoscopies). Patients with stenosis were excluded. According to patient preferences, CCE was performed the following day (protocol A) after staying on clear liquids and 0.75 L Moviprep in the morning or within 30 d after new split-dose Moviprep (protocol B). Boosts consisted of 0.75 L and 0.25 L Moviprep, and phospho-soda was given as a rescue if the capsule was not excreted after seven hours.
Results: Seventy-four patients were analysed (51% of them in group A; 49% in group B). Bowel cleansing was adequate in 67% of cases, and CCE could visualize colonic segments missed by incomplete colonoscopy in 90% of patients under protocol A and 97% of patients under protocol B (P = 0.35, n.s.). Significant polyps including adenocarcinoma were detected in 24% of cases. Detection rates for all polyps and significant polyps per patient were similar in both protocols. Polyps were found predominantly in the right colon (86%) in segments that were not reached by OC. Extracolonic findings - such as reflux esophagitis, suspected Barrett esophagus, upper GI-bleeding, gastric polyps, gastric erosions and angiectasia - were detected in eight patients. PillCamColon2 capsule was retained in the ileum of one patient (1.4%) without symptoms and removed during an uneventful resection for unknown Crohn’s disease that was diagnosed as the cause of anemia, which was the indication for colonoscopy. CCE was well tolerated. One patient suffered from self-limiting vomiting after consuming the phospho-soda.
Conclusion: Second-generation CCE using a low-volume preparation is useful after incomplete OC, and it allows for the detection of additional relevant findings, but cleansing efficiency could be improved.